HCW Biologics Inc. (HCWB) earnings
HCWB earnings moved a median of +0.20% by the close. Quarterly and annual HCWB reports and results, each read against the price at its own news timestamp. Back to the HCWB overview →
27 measured HCWB earnings events.
Where these HCWB earnings landedvs 27 measured HCWB earnings reactions
| Middle 50% of HCWB earnings reactions | -3.43% to +2.21% |
|---|---|
| Median reaction (to close) | +0.20% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 HCWB earnings events with a measured close landed between -3.43% and +2.21%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q HCW Biologics Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.12% | +0.00% | |
| Form 10-Q/A HCW Biologics Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.94% | +1.13% | |
| HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results | Press release | -3.39% | -4.46% | |
| Form 10-Q HCW Biologics Inc. For: Mar 31 | SEC filing · Form 10-Q | +17.27% | +10.91% | |
| HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results | Press release | +17.27% | +10.91% | |
| Form 10-K HCW Biologics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.03% | -9.09% | |
| HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results | Press release | +0.03% | -9.09% | |
| Form 10-Q HCW Biologics Inc. For: Sep 30 | SEC filing · Form 10-Q | -8.38% | +1.32% | |
| HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results | Press release | -8.38% | +1.32% | |
| Form 10-Q HCW Biologics Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.03% | +3.08% | |
| HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results | Press release | -10.73% | -1.95% | |
| Form NT 10-Q HCW Biologics Inc. For: Jun 30 | SEC filing · Form NT | +0.00% | -4.21% | |
| Form 10-Q HCW Biologics Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.98% | +9.15% | |
| HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results | Press release | +0.98% | +9.15% | |
| Form 10-K HCW Biologics Inc. For: Dec 31 | SEC filing · Form 10-K | +1.05% | +1.35% | |
| Form 10-Q HCW Biologics Inc. For: Sep 30 | SEC filing · Form 10-Q | +3.64% | +8.27% | |
| HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights | Press release | +3.64% | +8.27% | |
| HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction | Press release | — | -15.44% | |
| Form 10-Q HCW Biologics Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.20% | |
| HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights | Press release | +0.00% | +0.20% | |
| Form 10-K/A HCW Biologics Inc. For: Dec 31 | SEC filing · Form 10-K | -2.65% | -2.65% | |
| Form 10-Q HCW Biologics Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.65% | -2.65% | |
| HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights | Press release | -2.65% | -2.65% | |
| Form 10-K HCW Biologics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.61% | |
| HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights | Press release | +0.00% | +0.61% | |
| Form 10-Q HCW Biologics Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.49% | -13.43% | |
| HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights | Press release | -1.49% | -13.43% |
Keep exploring
More HCWB: analyst actions → · SEC filings → · HCWB overview →